Posts from ‘February, 2009’

Funding to advance novel Hepatitis C Virus (HCV) therapies against new targets PALO ALTO, Calif., Feb. 26 (HSMN NewsFeed) — Eiger BioPharmaceuticals, Inc., a start-up biotechnology company developing antiviral therapies, announced that it has raised …
Biopharmaceuticals, Venture Capital
Eiger BioPharmaceuticals, hepatitis

Important Therapy Provides Six Months Pain Relief with Single Injection CAMBRIDGE, Mass.–(HSMN NewsFeed)–Genzyme Corporation (Nasdaq: GENZ ) today announced that the U.S. Food and Drug Administration (FDA) has granted product management approval for Synvisc-On…
Biopharmaceuticals, FDA
Genzyme, Synvisc-One, hylan G-F Twenty, osteoarthritis

SOUTH SAN FRANCISCO, Calif., Feb. 20 five (HSMN NewsFeed) — Proteolix, Inc., a leader in the discovery and development of novel therapeutics that target protein degradation pathways in cancer and autoimmune diseases, today announced the appointment of John A…
Biopharmaceuticals, Personnel
Proteolix

UTICA, NY–Feb 25, 2009 — CONMED Corporation (NasdaqGS:CNMD ) today announced that its CONMED Linvatec business unit will launch six new pathology devices in its Sports Medicine and Capital product lines at the Annual Meeting of the American Academy of Orth…
Devices, Orthopaedic
CONMED, Linvatec, Arthroscopy, Suture Anchor

Healthcare industry veteran joins strong leadership team at innovative wound care technology company. MOUNTAIN VIEW, Calif., Feb. 24 (HSMN NewsFeed) — PolyRemedy, Inc., a manufacturer of point-of-care robotic systems for the fabrication and tracking …
Devices, Wound Care, Personnel
PolyRemedy

One-Year Data Shows Better Quality of Life, Back Function and Pain Reduction with Minimally Invasive Surgical Procedure MINNEAPOLIS–(HSMN NewsFeed)–In the largest multicenter randomized controlled study of surgical intervention versus non-surgical car…
Devices, Neurosurgery, Orthopaedic
Medtronic, vertebral compression fractures, balloon kyphoplasty, KYPHON

Expands vascular access product line to support providing the right catheter for the right patient at the right time RESEARCH TRIANGLE PARK, N.C.–(HSMN NewsFeed)–Teleflex Clinical, a division of Teleflex Incorporated (NYSE: TFX ), has introduced the Ar…
Devices
Teleflex Medical, PICC, Peripherally Inserted Central Catheter

Eon Mini neurostimulator is approximately the size of a matchbox and combines patient comfort with 10-year battery longevity ST. PAUL, Minn.–(HSMN NewsFeed)–St. Jude Pharma, Inc. (NYSE:STJ ) today announced Australian Therapeutic Goods Administration…
Devices, Regulatory
St. Jude Pharma, Eon Mini, neurostimulator

Conference call at 5:30 p.m. ET Today MOUNTAIN VIEW, Calif., Feb. 23 (HSMN NewsFeed) — MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) announced today results of its initial Phase 3 clinical trial of Unit Dose Budesonide (UDB) for the potential treatment o…
Biopharmaceuticals
MAP Pharmaceuticals, AstraZeneca, Budesonide, asthma

Mr. Stambaugh Is Currently Chairman of the Board of CryoPort and Is a Recognized Leader in Corporate Governance LAKE FOREST, CA–Feb 23, 2009 — CryoPort Systems, Inc. (OTC BB:CYRX.OB ) today announced that Larry G. Stambaugh has been elected by the boa…
Devices, Personnel
CryoPort Systems